Casandra
Casandra Test Code AR19304Version 1 (DRAFT)
Performing Lab
KRAS Mutation Detection (Inactive as of 05/20/2024)
Also known as: KRAS
Clinical Use
Order TestUse
This ARUP test “KRAS Mutation Detection” was intended to detect somatic mutations in the KRAS gene, which are clinically significant due to their association with resistance to EGFR-targeted therapies across various cancers such as colorectal and lung carcinoma. It served predictive and prognostic purposes, and could influence therapeutic management decisions.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
PCR-based
Biomarkers
KRAS
GeneMutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Not provided.
Related Tests
Other tests from different labs that may be relevant
KRAS Gene Mutation Analysis, IVD
Labcorp
KRAS Somatic Mutation Analysis, Tumor
Mayo Clinic Lab
KRAS Mutation Analysis by PCR
NeoGenomics
KRAS Mutation Analysis (Extended) in Colorectal Cancer (CRC)
Labcorp
RAS Mutation Analysis, Cell-based
Quest Diagnostics
KRAS Mutation Analysis
Quest Diagnostics
KRAS and NRAS Mutation Analysis, Cell‑Based
Quest Diagnostics
Cell-Free DNA KRAS 12, 13, 61, 146, Blood
Mayo Clinic Lab
Colorectal Cancer Mutation Panel (KRAS, PIK3CA, BRAF, NRAS)
Quest Diagnostics
Lung Cancer Mutation Panel (EGFR, KRAS, ALK)
Quest Diagnostics